KYNTRA BIO, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Yu K Peony | Chief Medical Officer | Sale | 6,107 | $17.60 | $107,483 | 214,011 | May 16, 2016 |
| Cotroneo Pat | VP, Finance and CFO | Sale | 6,107 | $17.60 | $107,483 | 141,868 | May 16, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 13,500 | $17.61 | $237,735 | 3,538,853 | May 2, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 13,500 | $20.21 | $272,835 | 3,579,353 | Apr 20, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 3,510 | $21.14 | $74,201 | 3,592,853 | Apr 4, 2016 |
| VALONE FRANK H MD | Chief Medical Officer | Sale | 10,550 | $21.10 | $222,605 | 104,884 | Apr 1, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 100 | $18.87 | $1,887 | 3,633,353 | Mar 21, 2016 |
| Tamura Toshinari | — | Option Exercise | 12,000 | $2.90 | $34,800 | 48,000 | Mar 16, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 2,200 | $19.85 | $43,670 | 3,646,853 | Mar 7, 2016 |
| VALONE FRANK H MD | Chief Medical Officer | Tax Withholding | 3,921 | $18.77 | $73,597 | 104,684 | Mar 3, 2016 |
| Cotroneo Pat | VP, Finance and CFO | Tax Withholding | 3,660 | $18.77 | $68,698 | 146,586 | Mar 3, 2016 |
| Yu K Peony | VP, Clinical Development | Tax Withholding | 3,660 | $18.77 | $68,698 | 218,729 | Mar 3, 2016 |
| Neff Thomas B | Chief Executive Officer | Tax Withholding | 8,554 | $18.77 | $160,559 | 3,673,853 | Mar 3, 2016 |
| VALONE FRANK H MD | Chief Medical Officer | Sale | 3,490 | $17.61 | $61,459 | 108,605 | Mar 1, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 13,200 | $19.80 | $261,360 | 3,596,207 | Feb 23, 2016 |
| Cotroneo Pat | VP, Finance and CFO | Award / Grant | 35,294 | — | — | 150,246 | Feb 22, 2016 |
| Yu K Peony | VP, Clinical Development | Award / Grant | 35,294 | — | — | 222,389 | Feb 22, 2016 |
| VALONE FRANK H MD | Chief Medical Officer | Award / Grant | 11,765 | — | — | 108,605 | Feb 22, 2016 |
| VALONE FRANK H MD | Chief Medical Officer | Sale | 10,750 | $18.41 | $197,908 | 96,840 | Feb 16, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 13,500 | $15.48 | $208,980 | 3,609,407 | Feb 9, 2016 |
| Cotroneo Pat | VP, Finance and CFO | Option Exercise | 3,627 | $2.90 | $10,518 | 114,952 | Feb 5, 2016 |
| Yu K Peony | VP, Clinical Development | Option Exercise | 4,500 | $5.95 | $26,775 | 187,095 | Feb 5, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 12,600 | $19.17 | $241,542 | 3,650,807 | Jan 29, 2016 |
| VALONE FRANK H MD | Chief Medical Officer | Option Exercise | 10,000 | $2.90 | $29,000 | 96,840 | Jan 22, 2016 |
| KEARNS THOMAS F JR | — | Sale | 1,572 | $22.08 | $34,710 | 160,564 | Jan 21, 2016 |
| Cotroneo Pat | VP, Finance and CFO | Option Exercise | 4,000 | $2.90 | $11,600 | 111,325 | Jan 21, 2016 |
| Neff Thomas B | Chief Executive Officer | Sale | 3,900 | $24.42 | $95,238 | 3,676,907 | Jan 13, 2016 |
| Routti Jorma | — | Option Exercise | 8,000 | $2.00 | $16,000 | 115,840 | Dec 28, 2015 |
| KEARNS THOMAS F JR | — | Sale | 3,900 | $30.94 | $120,666 | 166,036 | Dec 24, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 13,500 | $30.93 | $417,555 | 3,690,407 | Dec 22, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Gift | 2,500 | — | — | 86,840 | Dec 17, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Sale | 837 | $28.95 | $24,231 | 107,325 | Dec 15, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 1,093 | $28.96 | $31,653 | 176,595 | Dec 10, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 6,900 | $30.35 | $209,415 | 3,730,907 | Dec 10, 2015 |
| MADERO MIGUEL | — | Option Exercise | 12,000 | $3.50 | $42,000 | 66,000 | Dec 8, 2015 |
| Rosenkranz Roberto Pedro | — | Option Exercise | 4,000 | $2.90 | $11,600 | 39,000 | Dec 4, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Tax Withholding | 913 | $29.88 | $27,280 | 106,862 | Dec 3, 2015 |
| Yu K Peony | VP, Clinical Development | Tax Withholding | 657 | $29.88 | $19,631 | 177,688 | Dec 1, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Tax Withholding | 704 | $29.88 | $21,036 | 93,340 | Dec 1, 2015 |
| Neff Thomas B | Chief Executive Officer | Tax Withholding | 2,282 | $29.88 | $68,186 | 3,744,407 | Dec 1, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 344 | $30.00 | $10,320 | 183,001 | Nov 30, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Option Exercise | 5,000 | $2.35 | $11,750 | 112,775 | Nov 25, 2015 |
| KEARNS THOMAS F JR | — | Sale | 1,000 | $28.46 | $28,460 | 172,836 | Nov 23, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 9,700 | $29.19 | $283,143 | 3,746,689 | Nov 23, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 5,000 | $28.00 | $140,000 | 183,345 | Nov 17, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Option Exercise | 10,000 | $2.90 | $29,000 | 94,044 | Nov 13, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 2,500 | $25.00 | $62,500 | 190,404 | Nov 10, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Sale | 8,655 | $23.08 | $199,757 | 85,389 | Nov 2, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 3,500 | $24.65 | $86,275 | 3,787,189 | Oct 29, 2015 |
| KEARNS THOMAS F JR | — | Sale | 3,100 | $24.17 | $74,927 | 182,436 | Oct 20, 2015 |